Recruitment Challenges for Studies of Deep Brain Stimulation for Treatment-Resistant Depression
Authors Ramasubbu R, Golding S, Williams K, Mackie A, MacQueen G, Kiss ZHT
Received 31 December 2020
Accepted for publication 13 February 2021
Published 10 March 2021 Volume 2021:17 Pages 765—775
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Roger Pinder
Rajamannar Ramasubbu,1– 4 Sandra Golding,1,2 Kimberly Williams,1 Aaron Mackie,1 Glenda MacQueen,1,3,4 Zelma HT Kiss1– 4
1Department of Psychiatry, University of Calgary, Calgary, AB, Canada; 2Department of Clinical Neuroscience, University of Calgary, Calgary, AB, Canada; 3Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada; 4Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada
Correspondence: Rajamannar Ramasubbu
Department of Psychiatry/Clinical Neurosciences, University of Calgary, Mathison Centre for Mental Health Research and Education, TRW Building, Room 4D64, 3280 Hospital Drive NW, Calgary, Alberta, T2N4Z6 Tel +1 403 210 6890
Fax +1 403 210 9114
Email [email protected]
Introduction: Deep brain stimulation (DBS) is currently an investigational treatment for treatment-resistant depression (TRD). There is a need for more DBS trials to strengthen existing evidence of its efficacy for both regulatory and clinical reasons. Recruitment for DBS trials remains challenging due to unproven efficacy in sham-controlled DBS trials, invasive nature of the intervention and stringent eligibility criteria in patient selection. Here, we examined the referral patterns and reasons for exclusion of subjects in our DBS trial.
Methods: Data were collected from all patients who expressed interest in participating in a DBS study involving subcallosal cingulate region from 2014 to 2016. Referral sources were categorized as either self-referral or professional referral. Evaluation for eligibility was performed in three stages; initial contact, brief telephone assessment, and in-person psychiatric evaluation. The reasons for exclusion were documented. Descriptive and inferential statistics were used for analysis.
Results: Of the 225 patients who contacted us initially, 22 (9.2%) underwent DBS surgery. Self-referral was higher than the referral from professionals (72% versus 28%, P< 0.0001). However, the acceptance rate for surgery was higher among the professional referrals than from self-referrals (40% versus 15%, P=0.03). The common reasons for exclusion were self-withdrawal (38.4%), residing out of province or country (26.1%) and psychiatric/medical comorbidity (21.7%).
Conclusion: These findings provide insight into DBS candidacy for future TRD trials. It suggests a need for comprehensive recruitment strategies including active engagement of patients and professionals throughout trials, and effective referral communication with education to optimize recruitment for future DBS trials.
Keywords: patient recruitment, deep brain stimulation, treatment-resistant depression, clinical trials, subcallosal cingulate region
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]